MARCANTONIO, PAMELA
 Distribuzione geografica
Continente #
EU - Europa 645
NA - Nord America 625
AS - Asia 325
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.605
Nazione #
US - Stati Uniti d'America 624
CN - Cina 150
IT - Italia 102
IE - Irlanda 91
UA - Ucraina 90
SE - Svezia 89
FR - Francia 82
DE - Germania 77
TR - Turchia 76
GB - Regno Unito 71
SG - Singapore 70
IN - India 26
FI - Finlandia 22
RU - Federazione Russa 14
EG - Egitto 7
CZ - Repubblica Ceca 3
EU - Europa 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
KR - Corea 1
LT - Lituania 1
NL - Olanda 1
NO - Norvegia 1
Totale 1.605
Città #
Chandler 135
Jacksonville 117
Dublin 88
Southend 66
Singapore 64
Princeton 44
New York 40
Izmir 36
Beijing 33
Dearborn 29
Munich 29
Nanjing 29
Chieti 26
Cambridge 19
Wilmington 17
Shenyang 16
Los Angeles 14
Nanchang 14
Ashburn 12
Santa Clara 11
Jinan 8
Mountain View 8
Ningbo 8
Rome 8
Pescara 7
Tianjin 6
Jiaxing 5
Kunming 5
Zhengzhou 5
Grevenbroich 4
Hebei 4
Boardman 3
Brno 3
Cairo 3
Changsha 3
Duncan 3
Frankfurt am Main 3
Helsinki 3
Lanzhou 3
Norwalk 3
Notaresco 3
Padova 3
San Vito Chietino 3
Spoltore 3
Washington 3
Altamura 2
Ann Arbor 2
Changchun 2
Dong Ket 2
Falls Church 2
London 2
Palosco 2
Roda 2
Simi Valley 2
Ancona 1
Campobasso 1
Dong-gu 1
Fuzhou 1
Guardiagrele 1
Hangzhou 1
Hefei 1
Lanciano 1
Moscow 1
Oslo 1
Quzhou 1
Raleigh 1
Seattle 1
Sofia 1
Taizhou 1
Toronto 1
Townsville 1
Vaglia 1
Varallo 1
Zhongxin 1
Totale 987
Nome #
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 125
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 90
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 88
Effect of Rosuvastatin on ABCA1 and ABCG1 expression in human atherosclerotic plaques: results from the QUASAR study 86
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 84
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 82
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 80
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 80
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 77
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 73
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 72
null 71
Hypertension modulates miR-145 expression in human atherosclerotic plaques 70
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 69
High dose Rosuvastatin modulates MicroRNA-222 expression in advanced human atherosclerotic plaques 68
Effect of Rosuvastatin on MicroRNAs expression in Human Atherosclerotic Plaques: Results from Quasar Study 65
MicroRNAs profiling in human atherosclerotic plaques 62
MicroRNAs involvment in ABCA1 pathway regulation in human atherosclerotic plaques 62
null 61
Effects of Rosuvastatin on the expression of microRNAs and their putative targets in human atherosclerotic plaques: the QUASAR Study 57
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes 50
MicroRNA profiling in migraine without aura: Pilot study 35
Identification of microRNAs 758 and 33b as potential modulators ofABCA1 expression in human atherosclerotic plaques 28
Totale 1.635
Categoria #
all - tutte 5.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 0 0 0 0 28 23 47 27 5 46 30 8
2020/2021109 19 0 22 11 0 20 1 1 20 13 0 2
2021/2022103 0 3 0 29 5 3 2 6 10 2 11 32
2022/2023339 23 46 19 21 36 75 18 26 52 4 10 9
2023/2024184 15 4 5 10 6 68 33 1 0 10 0 32
2024/2025132 14 43 51 1 23 0 0 0 0 0 0 0
Totale 1.635